HOME >> BIOLOGY >> NEWS
Children's Hospital Boston launches major genetic study of autism

Children's Hospital Boston has begun enrolling patients as part of an ambitious new multidisciplinary study of autism that will attempt to pin down its genetic and biochemical causes. Results could be available in a year or two, and could yield a greater biological understanding of autistic spectrum disorders, better diagnostic and prognostic techniques, and potential medical treatments.

More than 90 percent of autism cases are believed to have a genetic component, and multiple genes are believed to be involved. But although much research has been done and many candidate genes identified, none have been clearly implicated. The Children's study, partially funded by the Nancy Lurie Marks Family Foundation, will bring together researchers in genetics, genomics, bioinformatics, and developmental medicine to try to solve the puzzle.

Autism is a complex behavioral syndrome defined by developmental deficits, particularly communication deficits, impaired social interaction and repetitive behaviors. Affecting about one in 1,000 people, it is now thought of as a spectrum of disorders including autism, Asperger's syndrome and pervasive developmental disorder. There is no specific medical treatment, although behavioral interventions help children on the autistic spectrum live fuller, more functional lives.

The Children's researchers plan to enroll 100 to 150 children age 2 years and older per year, along with their parents and affected siblings. They also will enroll 150 unaffected children to serve as controls. The study has several components:

  • The Children's Developmental Medicine Center will first conduct detailed behavioral evaluations of the children and their families, led by Drs. Janice Ware and Leonard Rappaport. Subjects will be assessed for autistic spectrum disorders and carefully classified according to rigorous clinical research criteria. The goal is to develop behavioral profiles that can be correlated with genetic d
    '"/>


Contact: Aaron Patnode
aaron.patnode@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
9-Dec-2004


Page: 1 2 3

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
3. Childrens Hospital Oakland, Calif.s new iron regulation discovery
4. Childrens Hospital researcher leads multipronged attack on infant leukemia
5. Childrens Hospital Oaklands new maternal diet study
6. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
7. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
8. Genetic research at Childrens Hospital of Pittsburgh reinforces theory of evolution
9. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
10. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
11. Childrens Hospital Oakland scientist awarded seat on national scientific review board

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader ... that uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in ... and safety of employees returning to the workplace. , “Some of the best ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will ... which will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown ...
(Date:5/25/2020)... ... 2020 , ... Oxford Nanopore Technologies is in advanced development of a new ... COVID-19. , The LamPORE assay is designed to be rapid, low cost, ... numbers of samples. Hardware and reagents sit outside current, squeezed supply chains for ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell banks and hMSC bioprocess systems, today announced the launch of its ... extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product ...
(Date:5/15/2020)... Mass. (PRWEB) , ... May 15, 2020 , ... Sentien ... the appointment of Richard Ganz as Executive Chairman. Mr. Ganz will continue to ... years, as well as work closely with CEO Brian Miller and Sentien’s management team. ...
(Date:5/14/2020)... ... 2020 , ... In collaboration with Sartorius, Biocompare has introduced ... Science Lab . The comprehensive information source was created for life scientists to ... to contamination control. , The content hub features the latest guidance about enabling ...
(Date:5/5/2020)... , ... May 04, 2020 , ... ... solutions for the life sciences industry, today announced that Informa Training Partners, a ... changing its name to Red Nucleus Boston, effective immediately. , “The name change ...
Breaking Biology Technology:
Cached News: